CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+12.33%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$15.6B
AUM Growth
+$1.15B
(+7.9%)
Cap. Flow
-$216M
Cap. Flow
% of AUM
-1.38%
Top 10 Holdings %
Top 10 Hldgs %
27.58%
Holding
755
New
44
Increased
354
Reduced
220
Closed
56
Top Buys
| 1 |
NVIDIA
NVDA
|
+$80.1M |
| 2 |
Salesforce
CRM
|
+$55.1M |
| 3 |
Micron Technology
MU
|
+$53.8M |
| 4 |
Apple
AAPL
|
+$50M |
| 5 |
Applied Materials
AMAT
|
+$48.3M |
Top Sells
| 1 |
Merck
MRK
|
+$73.5M |
| 2 |
ANSS
Ansys
ANSS
|
+$53.4M |
| 3 |
Adobe
ADBE
|
+$51.7M |
| 4 |
TJX Companies
TJX
|
+$41.4M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$39.6M |
Sector Composition
| 1 | Technology | 31.73% |
| 2 | Healthcare | 28.37% |
| 3 | Financials | 8.73% |
| 4 | Consumer Discretionary | 8.29% |
| 5 | Industrials | 6.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Travelers Companies
TRV
$61.6B
| $5.34M | 0.03% |
23,199
+770
| +3% | +$177K |
|
327
Pacira BioSciences
PCRX
$1.18B
| $5.32M | 0.03% |
181,901
-10,000
| -5% | -$292K |
|
328
Blackstone
BX
$135B
| $5.26M | 0.03% |
40,023
+1,613
| +4% | +$212K |
|
329
Kinder Morgan
KMI
$59.2B
| $5.22M | 0.03% |
284,725
+25,808
| +10% | +$473K |
|
330
W.W. Grainger
GWW
$47.6B
| $5.2M | 0.03% |
5,107
+51
| +1% | +$51.9K |
|
331
West Fraser Timber
WFG
$5.85B
| $5.18M | 0.03% |
59,885
-15,650
| -21% | -$1.35M |
|
332
Tanger
SKT
$3.9B
| $5.15M | 0.03% |
+174,277
| New | +$5.15M |
|
333
Power Integrations
POWI
$2.51B
| $5.14M | 0.03% |
71,826
| – | – |
|
334
Take-Two Interactive
TTWO
$45.7B
| $5.12M | 0.03% |
34,463
-32,501
| -49% | -$4.83M |
|
335
Prudential Financial
PRU
$37.1B
| $5.03M | 0.03% |
42,873
+3,158
| +8% | +$371K |
|
336
Chipotle Mexican Grill
CMG
$52.9B
| $5M | 0.03% |
86,000
+7,150
| +9% | +$416K |
|
337
Disc Medicine
IRON
$2.1B
| $4.98M | 0.03% |
80,000
| – | – |
|
338
Stantec
STN
$12.3B
| $4.94M | 0.03% |
59,457
+22,478
| +61% | +$1.87M |
|
339
Viridian Therapeutics
VRDN
$1.65B
| $4.9M | 0.03% |
+280,000
| New | +$4.9M |
|
340
Globus Medical
GMED
$7.98B
| $4.87M | 0.03% |
90,792
+37,735
| +71% | +$2.02M |
|
341
Williams Companies
WMB
$70.3B
| $4.87M | 0.03% |
124,884
+4,529
| +4% | +$176K |
|
342
PTC Therapeutics
PTCT
$4.64B
| $4.86M | 0.03% |
167,048
-124,604
| -43% | -$3.62M |
|
343
PACCAR
PCAR
$51.2B
| $4.85M | 0.03% |
39,174
+1,167
| +3% | +$145K |
|
344
Phillips 66
PSX
$53.5B
| $4.83M | 0.03% |
29,577
+2,518
| +9% | +$411K |
|
345
Madrigal Pharmaceuticals
MDGL
$10B
| $4.81M | 0.03% |
18,000
-9,000
| -33% | -$2.4M |
|
346
Day One Biopharmaceuticals
DAWN
$759M
| $4.79M | 0.03% |
290,014
| – | – |
|
347
Schrodinger
SDGR
$1.43B
| $4.78M | 0.03% |
177,000
+35,000
| +25% | +$945K |
|
348
Edwards Lifesciences
EW
$46.9B
| $4.75M | 0.03% |
49,663
+1,742
| +4% | +$166K |
|
349
Vera Therapeutics
VERA
$1.6B
| $4.66M | 0.03% |
+108,000
| New | +$4.66M |
|
350
United Rentals
URI
$60.8B
| $4.64M | 0.03% |
6,428
-34,883
| -84% | -$25.2M |
|